Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Morgan Stanley Maintains Equal-Weight on Quest Diagnostics, Raises Price Target to $146

Morgan Stanley analyst Ricky Goldwasser maintains Quest Diagnostics (NYSE:DGX) with a Equal-Weight and raises the price target from $142 to $146.
byBenzinga Newsdesk
October 21, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Morgan Stanley analyst Ricky Goldwasser maintains Quest Diagnostics (NYSE:DGX) with a Equal-Weight and raises the price target from $142 to $146.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts